Phoenix, AZ – January 20, 2015 – Mission3, a leading provider of cloud-based and enterprise regulatory information management, clinical trial master file, and promotional materials management solutions for the life sciences industry, is changing its name to arivis in coordination with its parent company arivis, AG. arivis will combine Mission3’s cloud-based Clireo product and regulatory services as well as its enterprise GlobalTrack regulatory information management (RIM) product with arivis AG’s high-resolution, 3D+ image management solution to provide a high-value portfolio of solutions for life science, academic research, and healthcare clients.
Author Archive: AZBio
Can you stretch a dollar?
Learn how AZBio Purchasing Programs to help your dollars take you farther.Continue reading
Job Alert: Senior Manager of Research and Development at Pinnacle Trasplant
Pinnacle Transplant is currently seeking a Research and Development Senior Manager. Continue reading
Bills to Repeal the Medical Device Tax Introduced in the House and Senate
Momentum for repeal of the Medical Device Excise Tax is building in the 114th Congress.Continue reading
CFAST Launches Two New CDISC Therapeutic Area Standards for Influenza and QT Studies
The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. (“TransCelerate”) announced today that version 1.0 of the CDISC Influenza Therapeutic Area User Guide (TAUG) and version 1.0 of the CDISC QT Studies TAUG are now available for implementers on the CDISC website. CDISC standards facilitate clinical research from end-to-end, from protocol and data collection through analysis and reporting, and have been shown to significantly decrease the time and cost of medical research while improving quality.Continue reading
Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015
Plans to Submit NDA for Dronabinol Oral Solution in First Quarter of 2015Continue reading
Applications Open for Helios Scholars at TGen
TGen’s paid summer internship program in biomedical research – Helios Scholars at TGen – is now accepting applications through Feb. 13. Continue reading
Global Cancer Diagnostics Grants First International License for The Lung Cancer Test™ to Bertech Pharma Ltd.
The Lung Cancer Test is Proven to Screen High Risk Patient Populations for the Early Detection of Lung Cancer and will Soon Be Available in Canada